OLD Category: immuno-oncology

Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma

• Sorenson L et al., (Fu Y)

Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures

• Sabry M et al.,

A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma

• Shi L. et. al.,

Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes

• Lu C et al.,

Defining the microenvironment landscape of bladder cancer using highly multiplexed spatial genomic and proteomic analysis

• Reeves JW et al.,

Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity

• Snyder AG et al.,

Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer

• Sceneay J et al.,

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment

• Pileri SA et al.,

The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma

• Keane C et al.,

Rebalancing protein homeostasis enhances tumor antigen presentation

• Jaeger AM et al.,

Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers

• Liu JF et al.,

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod

• Rozenblit M et al.,